Related Experiment Videos
A case of paraneoplastic retinopathy
A Oohira1, Y Tamaki, K Nagahara
1Department of Ophthalmology, University of Tokyo, School of Medicine, Japan.
Japanese Journal of Ophthalmology
|January 1, 1993
Summary
A 62-year-old man experienced vision loss due to paraneoplastic retinopathy linked to lung adenocarcinoma. Tumor removal offered temporary visual improvement, highlighting the connection between cancer and neurological eye conditions.
Area of Science:
- Ophthalmology
- Neurology
- Oncology
Background:
- Paraneoplastic retinopathy is a rare autoimmune condition where the immune system mistakenly attacks the retina.
- Lung adenocarcinoma can present with paraneoplastic syndromes affecting various organs, including the eyes.
Observation:
- A 62-year-old male presented with sudden visual loss, photopsia, decreased visual acuity, and ring scotoma.
- Ophthalmic examination revealed narrowed retinal arteries, reduced electroretinogram responses, and characteristic fluorescein angiography findings.
- The patient had a history of lung lobectomy for adenocarcinoma, diagnosed after the onset of visual symptoms.
Findings:
- Surgical resection of the lung adenocarcinoma led to partial recovery of visual acuity and reduction in photopsia.
- Recurrence of visual symptoms after 8 months indicated potential persistent or relapsed paraneoplastic activity.
- Long-term steroid therapy was initiated to manage the ongoing autoimmune retinal inflammation.
Implications:
- This case underscores the critical link between oncological diagnosis and paraneoplastic neurological/ophthalmological manifestations.
- Early recognition of paraneoplastic retinopathy is crucial for timely cancer detection and management.
- Ophthalmological monitoring is essential in patients with cancer to detect and manage potential ocular complications.